Showing results (891-900 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|May 10, 2024
Critical re-evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failureMilton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|May 11, 2024
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialScott D Solomon, John W Ostrominski, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|May 10, 2024
Iron homeostasis, recycling and vulnerability in the stressed kidney: A neglected dimension of iron-deficient heart failureMilton Packer
European Journal of Heart Failure|May 24, 2024
Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESCGiuseppe M C Rosano, Davide Stolfo, Lisa Anderson, et al.
European Journal of Heart Failure|April 12, 2024
Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long-term outcomesMichael R Zile, JoAnn Lindenfeld, Fred A Weaver, et al.
European Journal of Heart Failure|April 12, 2024
Impact of guideline-directed medical therapy on systolic blood pressure and cardiovascular outcomes in patients with heart failure and low blood pressure: A systematic review and meta-analysisJingwei Li, Yunlong Chen, Yi Wang, et al.
European Journal of Heart Failure|November 29, 2025
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidisAldostefano Porcari, Paolo Milani, Simone Longhi, et al.
European Journal of Heart Failure|December 18, 2024
Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trialsAlberto Foà, Maria A Pabon, Eugene Braunwald, et al.
European Journal of Heart Failure|January 10, 2025
Sacubitril/valsartan versus valsartan initiation in patients naïve to renin-angiotensin system inhibitors: Insights from PARAGLIDE-HFNina Nouhravesh, Alexander H Gunn, Derek Cyr, et al.
European Journal of Heart Failure|December 26, 2024
Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trialMark C Petrie, Jacob A Udell, Stefan D Anker, et al.
Pageof 398